APO Research
Talk to an analyst

APO RESEARCH · REPORT

CMC Biosafety Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global CMC Biosafety Testing Market Outlook and Growth Opportunities 2026

5 June 2026216 pages

Choose your research edition.

Industry ResearchCMC Biosafety Testing Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal CMC Biosafety Testing Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal CMC Biosafety Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CMC Biosafety Testing Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal CMC Biosafety Testing Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global CMC Biosafety Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for CMC Biosafety Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for CMC Biosafety Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for CMC Biosafety Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the CMC Biosafety Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the CMC Biosafety Testing market include WuXi Biologics, Wuhan Canvest Biotechnology, Centre Testing International (CTI), Suzhou Liangchen Biotechnology, JADE Biomedical, Standard Testing Group, Sino Tech World Biologicals, Q2 Solutions and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global CMC Biosafety Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of CMC Biosafety Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents CMC Biosafety Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global CMC Biosafety Testing market.

CMC Biosafety Testing Segment by Company

WuXi Biologics

Wuhan Canvest Biotechnology

Centre Testing International (CTI)

Suzhou Liangchen Biotechnology

JADE Biomedical

Standard Testing Group

Sino Tech World Biologicals

Q2 Solutions

Merck

Charles River Laboratories

Sartorius

Eurofins Scientific

CAS Testing Technical Services

SGS

Samsung Biologics

NTEK

Texcell

Sino Biological

Miracle Points

Suzhou Cefety Bioscience

Zhejiang Hengyu Biological

CMC Biosafety Testing Segment by Type

Raw Materials

Viral Banks

Cell Banks

Others

CMC Biosafety Testing Segment by Application

Pharmaceutical and Biotechnology Companies

CROs and CDMOs

Academic and Research Institutions

CMC Biosafety Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global CMC Biosafety Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the CMC Biosafety Testing key companies, revenue, market share, and recent developments.

3. To split the CMC Biosafety Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions CMC Biosafety Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify CMC Biosafety Testing significant trends, drivers, influence factors in global and regions.

6. To analyze CMC Biosafety Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CMC Biosafety Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CMC Biosafety Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CMC Biosafety Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global CMC Biosafety Testing industry.

Chapter 3: Detailed analysis of CMC Biosafety Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of CMC Biosafety Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of CMC Biosafety Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. CMC Biosafety Testing Industry Trends Table 2. CMC Biosafety Testing Industry Drivers Table 3. CMC Biosafety Testing Industry Opportunities and Challenges Table 4. CMC Biosafety Testing Industry Restraints Table 5. Global CMC Biosafety Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global CMC Biosafety Testing Revenue Share by Company (2021-2026) Table 7. Global CMC Biosafety Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global CMC Biosafety Testing Key Company Manufacturing Base & Headquarters Table 9. Global CMC Biosafety Testing Company, Product Type & Application Table 10. Global CMC Biosafety Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global CMC Biosafety Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Raw Materials Table 15. Significant Companies of Viral Banks Table 16. Significant Companies of Cell Banks Table 17. Significant Companies of Others Table 18. Global CMC Biosafety Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global CMC Biosafety Testing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global CMC Biosafety Testing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global CMC Biosafety Testing Sales Value Share by Type (2021-2026) Table 22. Global CMC Biosafety Testing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical and Biotechnology Companies Table 24. Significant Companies of CROs and CDMOs Table 25. Significant Companies of Academic and Research Institutions Table 26. Global CMC Biosafety Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global CMC Biosafety Testing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global CMC Biosafety Testing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global CMC Biosafety Testing Sales Value Share by Application (2021-2026) Table 30. Global CMC Biosafety Testing Sales Value Share by Application (2027-2032) Table 31. Global CMC Biosafety Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global CMC Biosafety Testing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global CMC Biosafety Testing Sales Value Share by Region (2021-2026) Table 34. Global CMC Biosafety Testing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global CMC Biosafety Testing Sales Value Share by Region (2027-2032) Table 36. Global CMC Biosafety Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global CMC Biosafety Testing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global CMC Biosafety Testing Sales Value Market Share by Country (2021-2026) Table 39. Global CMC Biosafety Testing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global CMC Biosafety Testing Sales Value Market Share by Country (2027-2032) Table 41. WuXi Biologics Company Information Table 42. WuXi Biologics Business Overview Table 43. WuXi Biologics CMC Biosafety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. WuXi Biologics CMC Biosafety Testing Product Portfolio Table 45. WuXi Biologics Recent Development Table 46. Wuhan Canvest Biotechnology Company Information Table 47. Wuhan Canvest Biotechnology Business Overview Table 48. Wuhan Canvest Biotechnology CMC Biosafety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Wuhan Canvest Biotechnology CMC Biosafety Testing Product Portfolio Table 50. Wuhan Canvest Biotechnology Recent Development Table 51. Centre Testing International (CTI) Company Information Table 52. Centre Testing International (CTI) Business Overview Table 53. Centre Testing International (CTI) CMC Biosafety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Centre Testing International (CTI) CMC Biosafety Testing Product Portfolio Table 55. Centre Testing International (CTI) Recent Development Table 56. Suzhou Liangchen Biotechnology Company Information Table 57. Suzhou Liangchen Biotechnology Business Overview Table 58. Suzhou Liangchen Biotechnology CMC Biosafety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Suzhou Liangchen Biotechnology CMC Biosafety Testing Product Portfolio Table 60. Suzhou Liangchen Biotechnology Recent Development Table 61. JADE Biomedical Company Information Table 62. JADE Biomedical Business Overview Table 63. JADE Biomedical CMC Biosafety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. JADE Biomedical CMC Biosafety Testing Product Portfolio Table 65. JADE Biomedical Recent Development Table 66. Standard Testing Group Company Information Table 67. Standard Testing Group Business Overview Table 68. Standard Testing Group CMC Biosafety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Standard Testing Group CMC Biosafety Testing Product Portfolio Table 70. Standard Testing Group Recent Development Table 71. Sino Tech World Biologicals Company Information Table 72. Sino Tech World Biologicals Business Overview Table 73. Sino Tech World Biologicals CMC Biosafety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sino Tech World Biologicals CMC Biosafety Testing Product Portfolio Table 75. Sino Tech World Biologicals Recent Development Table 76. Q2 Solutions Company Information Table 77. Q2 Solutions Business Overview Table 78. Q2 Solutions CMC Biosafety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Q2 Solutions CMC Biosafety Testing Product Portfolio Table 80. Q2 Solutions Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck CMC Biosafety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Merck CMC Biosafety Testing Product Portfolio Table 85. Merck Recent Development Table 86. Charles River Laboratories Company Information Table 87. Charles River Laboratories Business Overview Table 88. Charles River Laboratories CMC Biosafety Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Charles River Laboratories CMC Biosafety Testing Product Portfolio Table 90. Charles River Laboratories Recent Development Table 91. Sartorius Company Information Table 92. Sartorius Business Overview Table 93. Sartorius CMC Biosafety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Sartorius CMC Biosafety Testing Product Portfolio Table 95. Sartorius Recent Development Table 96. Eurofins Scientific Company Information Table 97. Eurofins Scientific Business Overview Table 98. Eurofins Scientific CMC Biosafety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Eurofins Scientific CMC Biosafety Testing Product Portfolio Table 100. Eurofins Scientific Recent Development Table 101. CAS Testing Technical Services Company Information Table 102. CAS Testing Technical Services Business Overview Table 103. CAS Testing Technical Services CMC Biosafety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. CAS Testing Technical Services CMC Biosafety Testing Product Portfolio Table 105. CAS Testing Technical Services Recent Development Table 106. SGS Company Information Table 107. SGS Business Overview Table 108. SGS CMC Biosafety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. SGS CMC Biosafety Testing Product Portfolio Table 110. SGS Recent Development Table 111. Samsung Biologics Company Information Table 112. Samsung Biologics Business Overview Table 113. Samsung Biologics CMC Biosafety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Samsung Biologics CMC Biosafety Testing Product Portfolio Table 115. Samsung Biologics Recent Development Table 116. NTEK Company Information Table 117. NTEK Business Overview Table 118. NTEK CMC Biosafety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. NTEK CMC Biosafety Testing Product Portfolio Table 120. NTEK Recent Development Table 121. Texcell Company Information Table 122. Texcell Business Overview Table 123. Texcell CMC Biosafety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Texcell CMC Biosafety Testing Product Portfolio Table 125. Texcell Recent Development Table 126. Sino Biological Company Information Table 127. Sino Biological Business Overview Table 128. Sino Biological CMC Biosafety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Sino Biological CMC Biosafety Testing Product Portfolio Table 130. Sino Biological Recent Development Table 131. Miracle Points Company Information Table 132. Miracle Points Business Overview Table 133. Miracle Points CMC Biosafety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Miracle Points CMC Biosafety Testing Product Portfolio Table 135. Miracle Points Recent Development Table 136. Suzhou Cefety Bioscience Company Information Table 137. Suzhou Cefety Bioscience Business Overview Table 138. Suzhou Cefety Bioscience CMC Biosafety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Suzhou Cefety Bioscience CMC Biosafety Testing Product Portfolio Table 140. Suzhou Cefety Bioscience Recent Development Table 141. Zhejiang Hengyu Biological Company Information Table 142. Zhejiang Hengyu Biological Business Overview Table 143. Zhejiang Hengyu Biological CMC Biosafety Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Zhejiang Hengyu Biological CMC Biosafety Testing Product Portfolio Table 145. Zhejiang Hengyu Biological Recent Development Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. CMC Biosafety Testing Product Image Figure 2. Global CMC Biosafety Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global CMC Biosafety Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global CMC Biosafety Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Raw Materials Image Figure 8. Viral Banks Image Figure 9. Cell Banks Image Figure 10. Others Image Figure 11. Global CMC Biosafety Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global CMC Biosafety Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global CMC Biosafety Testing Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical and Biotechnology Companies Image Figure 15. CROs and CDMOs Image Figure 16. Academic and Research Institutions Image Figure 17. Global CMC Biosafety Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global CMC Biosafety Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global CMC Biosafety Testing Sales Value Share by Application (2021-2032) Figure 20. Global CMC Biosafety Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global CMC Biosafety Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America CMC Biosafety Testing Sales Value (2021-2032) & (US$ Million) Figure 23. North America CMC Biosafety Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe CMC Biosafety Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe CMC Biosafety Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific CMC Biosafety Testing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific CMC Biosafety Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America CMC Biosafety Testing Sales Value (2021-2032) & (US$ Million) Figure 29. South America CMC Biosafety Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa CMC Biosafety Testing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa CMC Biosafety Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt CMC Biosafety Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Raw Materials
  • Viral Banks
  • Cell Banks
  • Others
Applications
  • Pharmaceutical and Biotechnology Companies
  • CROs and CDMOs
  • Academic and Research Institutions
Companies covered
  • WuXi Biologics
  • Wuhan Canvest Biotechnology
  • Centre Testing International (CTI)
  • Suzhou Liangchen Biotechnology
  • JADE Biomedical
  • Standard Testing Group
  • Sino Tech World Biologicals
  • Q2 Solutions
  • Merck
  • Charles River Laboratories
  • Sartorius
  • Eurofins Scientific
  • CAS Testing Technical Services
  • SGS
  • Samsung Biologics
  • NTEK
  • Texcell
  • Sino Biological
  • Miracle Points
  • Suzhou Cefety Bioscience
  • Zhejiang Hengyu Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global CMC Biosafety Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global CMC Biosafety Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 CMC Biosafety Testing Market Dynamics
  1. 2.1 CMC Biosafety Testing Industry Trends
  2. 2.2 CMC Biosafety Testing Industry Drivers
  3. 2.3 CMC Biosafety Testing Industry Opportunities and Challenges
  4. 2.4 CMC Biosafety Testing Industry Restraints
3 CMC Biosafety Testing Market by Company
  1. 3.1 Global CMC Biosafety Testing Company Revenue Ranking in 2025
  2. 3.2 Global CMC Biosafety Testing Revenue by Company (2021-2026)
  3. 3.3 Global CMC Biosafety Testing Company Ranking (2024-2026)
  4. 3.4 Global CMC Biosafety Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global CMC Biosafety Testing Company Product Type and Application
  6. 3.6 Global CMC Biosafety Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global CMC Biosafety Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 CMC Biosafety Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 CMC Biosafety Testing Market by Type
  1. 4.1 CMC Biosafety Testing Type Introduction
  2. 4.1.1 Raw Materials
  3. 4.1.2 Viral Banks
  4. 4.1.3 Cell Banks
  5. 4.1.4 Others
  6. 4.2 Global CMC Biosafety Testing Sales Value by Type
  7. 4.2.1 Global CMC Biosafety Testing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global CMC Biosafety Testing Sales Value by Type (2021-2032)
  9. 4.2.3 Global CMC Biosafety Testing Sales Value Share by Type (2021-2032)
5 CMC Biosafety Testing Market by Application
  1. 5.1 CMC Biosafety Testing Application Introduction
  2. 5.1.1 Pharmaceutical and Biotechnology Companies
  3. 5.1.2 CROs and CDMOs
  4. 5.1.3 Academic and Research Institutions
  5. 5.2 Global CMC Biosafety Testing Sales Value by Application
  6. 5.2.1 Global CMC Biosafety Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global CMC Biosafety Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global CMC Biosafety Testing Sales Value Share by Application (2021-2032)
6 CMC Biosafety Testing Regional Value Analysis
  1. 6.1 Global CMC Biosafety Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global CMC Biosafety Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global CMC Biosafety Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global CMC Biosafety Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America CMC Biosafety Testing Sales Value (2021-2032)
  7. 6.3.2 North America CMC Biosafety Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe CMC Biosafety Testing Sales Value (2021-2032)
  10. 6.4.2 Europe CMC Biosafety Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific CMC Biosafety Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific CMC Biosafety Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America CMC Biosafety Testing Sales Value (2021-2032)
  16. 6.6.2 South America CMC Biosafety Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa CMC Biosafety Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa CMC Biosafety Testing Sales Value Share by Country, 2025 VS 2032
7 CMC Biosafety Testing Country-level Value Analysis
  1. 7.1 Global CMC Biosafety Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global CMC Biosafety Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global CMC Biosafety Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global CMC Biosafety Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt CMC Biosafety Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt CMC Biosafety Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt CMC Biosafety Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 WuXi Biologics
  2. 8.1.1 WuXi Biologics Company Information
  3. 8.1.2 WuXi Biologics Business Overview
  4. 8.1.3 WuXi Biologics CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 WuXi Biologics CMC Biosafety Testing Product Portfolio
  6. 8.1.5 WuXi Biologics Recent Developments
  7. 8.2 Wuhan Canvest Biotechnology
  8. 8.2.1 Wuhan Canvest Biotechnology Company Information
  9. 8.2.2 Wuhan Canvest Biotechnology Business Overview
  10. 8.2.3 Wuhan Canvest Biotechnology CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Wuhan Canvest Biotechnology CMC Biosafety Testing Product Portfolio
  12. 8.2.5 Wuhan Canvest Biotechnology Recent Developments
  13. 8.3 Centre Testing International (CTI)
  14. 8.3.1 Centre Testing International (CTI) Company Information
  15. 8.3.2 Centre Testing International (CTI) Business Overview
  16. 8.3.3 Centre Testing International (CTI) CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Centre Testing International (CTI) CMC Biosafety Testing Product Portfolio
  18. 8.3.5 Centre Testing International (CTI) Recent Developments
  19. 8.4 Suzhou Liangchen Biotechnology
  20. 8.4.1 Suzhou Liangchen Biotechnology Company Information
  21. 8.4.2 Suzhou Liangchen Biotechnology Business Overview
  22. 8.4.3 Suzhou Liangchen Biotechnology CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Suzhou Liangchen Biotechnology CMC Biosafety Testing Product Portfolio
  24. 8.4.5 Suzhou Liangchen Biotechnology Recent Developments
  25. 8.5 JADE Biomedical
  26. 8.5.1 JADE Biomedical Company Information
  27. 8.5.2 JADE Biomedical Business Overview
  28. 8.5.3 JADE Biomedical CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 JADE Biomedical CMC Biosafety Testing Product Portfolio
  30. 8.5.5 JADE Biomedical Recent Developments
  31. 8.6 Standard Testing Group
  32. 8.6.1 Standard Testing Group Company Information
  33. 8.6.2 Standard Testing Group Business Overview
  34. 8.6.3 Standard Testing Group CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Standard Testing Group CMC Biosafety Testing Product Portfolio
  36. 8.6.5 Standard Testing Group Recent Developments
  37. 8.7 Sino Tech World Biologicals
  38. 8.7.1 Sino Tech World Biologicals Company Information
  39. 8.7.2 Sino Tech World Biologicals Business Overview
  40. 8.7.3 Sino Tech World Biologicals CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sino Tech World Biologicals CMC Biosafety Testing Product Portfolio
  42. 8.7.5 Sino Tech World Biologicals Recent Developments
  43. 8.8 Q2 Solutions
  44. 8.8.1 Q2 Solutions Company Information
  45. 8.8.2 Q2 Solutions Business Overview
  46. 8.8.3 Q2 Solutions CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Q2 Solutions CMC Biosafety Testing Product Portfolio
  48. 8.8.5 Q2 Solutions Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck CMC Biosafety Testing Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Charles River Laboratories
  56. 8.10.1 Charles River Laboratories Company Information
  57. 8.10.2 Charles River Laboratories Business Overview
  58. 8.10.3 Charles River Laboratories CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Charles River Laboratories CMC Biosafety Testing Product Portfolio
  60. 8.10.5 Charles River Laboratories Recent Developments
  61. 8.11 Sartorius
  62. 8.11.1 Sartorius Company Information
  63. 8.11.2 Sartorius Business Overview
  64. 8.11.3 Sartorius CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sartorius CMC Biosafety Testing Product Portfolio
  66. 8.11.5 Sartorius Recent Developments
  67. 8.12 Eurofins Scientific
  68. 8.12.1 Eurofins Scientific Company Information
  69. 8.12.2 Eurofins Scientific Business Overview
  70. 8.12.3 Eurofins Scientific CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Eurofins Scientific CMC Biosafety Testing Product Portfolio
  72. 8.12.5 Eurofins Scientific Recent Developments
  73. 8.13 CAS Testing Technical Services
  74. 8.13.1 CAS Testing Technical Services Company Information
  75. 8.13.2 CAS Testing Technical Services Business Overview
  76. 8.13.3 CAS Testing Technical Services CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CAS Testing Technical Services CMC Biosafety Testing Product Portfolio
  78. 8.13.5 CAS Testing Technical Services Recent Developments
  79. 8.14 SGS
  80. 8.14.1 SGS Company Information
  81. 8.14.2 SGS Business Overview
  82. 8.14.3 SGS CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 SGS CMC Biosafety Testing Product Portfolio
  84. 8.14.5 SGS Recent Developments
  85. 8.15 Samsung Biologics
  86. 8.15.1 Samsung Biologics Company Information
  87. 8.15.2 Samsung Biologics Business Overview
  88. 8.15.3 Samsung Biologics CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Samsung Biologics CMC Biosafety Testing Product Portfolio
  90. 8.15.5 Samsung Biologics Recent Developments
  91. 8.16 NTEK
  92. 8.16.1 NTEK Company Information
  93. 8.16.2 NTEK Business Overview
  94. 8.16.3 NTEK CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 NTEK CMC Biosafety Testing Product Portfolio
  96. 8.16.5 NTEK Recent Developments
  97. 8.17 Texcell
  98. 8.17.1 Texcell Company Information
  99. 8.17.2 Texcell Business Overview
  100. 8.17.3 Texcell CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Texcell CMC Biosafety Testing Product Portfolio
  102. 8.17.5 Texcell Recent Developments
  103. 8.18 Sino Biological
  104. 8.18.1 Sino Biological Company Information
  105. 8.18.2 Sino Biological Business Overview
  106. 8.18.3 Sino Biological CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Sino Biological CMC Biosafety Testing Product Portfolio
  108. 8.18.5 Sino Biological Recent Developments
  109. 8.19 Miracle Points
  110. 8.19.1 Miracle Points Company Information
  111. 8.19.2 Miracle Points Business Overview
  112. 8.19.3 Miracle Points CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Miracle Points CMC Biosafety Testing Product Portfolio
  114. 8.19.5 Miracle Points Recent Developments
  115. 8.20 Suzhou Cefety Bioscience
  116. 8.20.1 Suzhou Cefety Bioscience Company Information
  117. 8.20.2 Suzhou Cefety Bioscience Business Overview
  118. 8.20.3 Suzhou Cefety Bioscience CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Suzhou Cefety Bioscience CMC Biosafety Testing Product Portfolio
  120. 8.20.5 Suzhou Cefety Bioscience Recent Developments
  121. 8.21 Zhejiang Hengyu Biological
  122. 8.21.1 Zhejiang Hengyu Biological Company Information
  123. 8.21.2 Zhejiang Hengyu Biological Business Overview
  124. 8.21.3 Zhejiang Hengyu Biological CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Zhejiang Hengyu Biological CMC Biosafety Testing Product Portfolio
  126. 8.21.5 Zhejiang Hengyu Biological Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst